Anticancer Biosciences
Chengdu
About Anticancer Biosciences
Anticancer Bioscience (ACB) is an international private company, commercialising discoveries emerging from China’s world-leading cancer research at the J. Michael Bishop Institute of Cancer Research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $30.3M
- Funding stage: Seed
- Last round: Seed (Oct 2021)
- Website: anticancerbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/anticancer-biosciences-7633 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.